Frangoul H A, Shaw D W, Hawkins D, Park J
Department of Hematology/Oncology, Children's Hospital and Regional Medical Center, Seattle, Washington, USA.
J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):457-9. doi: 10.1097/00043426-200009000-00015.
This report describes a case of diabetes insipidus associated with acute myelogenous leukemia. An 11-year-old boy presented with fatigue, polydipsia and polyuria. His evaluation revealed a diagnosis of acute myelogenous leukemia FAB-M2, and a water deprivation test confirmed the diagnosis of central diabetes insipidus. His brain magnetic resonance imaging (MRI) showed a thickened, enhancing pituitary stalk with absence of the normal hyperintense signal in the posterior pituitary. He was treated with systemic chemotherapy, intensive intrathecal therapy, and 1,000 cGy to the pituitary. The patient achieved a remission but continued to need desmopressin therapy to control his diabetes insipidus. Diabetes insipidus is a rare complication of acute myelogenous leukemia that can be caused by leukemic infiltration of the pituitary. The diabetes insipidus is irreversible despite intensive systemic and central nervous system chemotherapy and radiation.
本报告描述了一例与急性髓系白血病相关的尿崩症病例。一名11岁男孩出现疲劳、烦渴和多尿症状。他的检查结果显示诊断为急性髓系白血病FAB-M2型,禁水-加压素试验证实为中枢性尿崩症。他的脑部磁共振成像(MRI)显示垂体柄增厚且强化,垂体后叶正常的高信号消失。他接受了全身化疗、强化鞘内治疗以及垂体1000厘戈瑞的放疗。患者达到缓解,但仍需要去氨加压素治疗来控制尿崩症。尿崩症是急性髓系白血病的一种罕见并发症,可由白血病浸润垂体引起。尽管进行了强化的全身和中枢神经系统化疗及放疗,尿崩症仍不可逆。